GNFT - GENFIT

-

$undefined

N/A

(N/A)

GENFIT NASDAQ:GNFT

Location: Parc Eurasante 885 avenue Eugene Avinee, Hauts De France, 59120, France | Website: https://www.genfit.fr/ | Industry: Biological Product (except Diagnostic) Manufacturing | Sector: Manufacturing


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

304.6M

Cash

61.65M

Avg Qtr Burn

-10.39M

Short % of Float

0.16%

Insider Ownership

0.00%

Institutional Own.

0.15%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
Iqirvo® (elafibranor) Details
Primary biliary cholangitis, Liver disease

Approved

Quarterly sales

VS-01 Details
Acute-on-Chronic liver failure, Liver disease

Phase 2

Data readout

Nitazoxanide (NTZ) Details
Non-alcoholic steatohepatitis , Acute-on-Chronic liver failure, Liver disease

Phase 2

Initiation

GNS561 Details
Liver disease, Cholangiocarcinoma

Phase 1b

Data readout

Iqirvo® (elafibranor) Details
Non-alcoholic steatohepatitis

Failed

Discontinued